Training Example: Repatha (Amgen) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

Repatha (Amgen)

(https://repatha.com) 📸 Data Snapshot: June 19, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE High Bad Cholesterol (LDL-C) Treatment | Repatha® (evolocumab) (https://repatha.com)
Title

High Bad Cholesterol (LDL-C) Treatment | Repatha® (evolocumab)

Meta

Learn about how Repatha® helps to reduce risk of a heart attack & lower high bad cholesterol for adults at increased risk of a major cardiovascular event. See Full Safety & Prescribing Info.

H1 Repatha® can help
H2 Use your Repatha® (evolocumab) Co-Pay Card Today To Pay as Little as $25 for a 1-month supply or $50 for a 3-month supply.*
H2 by dramatically lowering LDL-C (bad cholesterol) and reducing your risk of a heart attack.
H2 Let’s get started–tell us more about you by making a selection below.
H2 I’ve NEVER had a heart attack or stroke, and I want to learn how to keep it that way.
H2 I HAVE had a heart attack or stroke, and I want to avoid another one.
H2 I’ve BEEN PRESCRIBED Repatha® already.
H2 Want to find a physician to help you with managing high LDL-C?
H2 System Error. Please try after sometime.
H2 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H3 The support you asked for + more to explore
H3 APPROVED USE
H3 SUMMARY OF TERMS AND CONDITIONS
H3 I. ELIGIBILITY
H3 II.PROGRAM BENEFITS
H3 III.PROGRAM DETAILS
H6 Approved Use
NAV_HEADER_REPEATED_BODY What is Repatha® (evolocumab)? (https://repatha.com/what-is-repatha/)
Title

What is Repatha® (evolocumab)?

Meta

Learn what Repatha® is and how it can dramatically lower bad cholesterol (LDL-C) & reduce risk of a heart attack for adults at increased risk of a major cardiovascular event. See Full Safety & Prescribing Info.

H1 Important Safety Information
H2 Use your Repatha® (evolocumab) Co-Pay Card Today To Pay as Little as $25 for a 1-month supply or $50 for a 3-month supply.*
H2 63%
H2 84%
H2 27%
H2 21%
H2 55%
H2 36%
H2 10 Years of Impact. Over 5 Million Patients Served Worldwide.* Still Committed to Lowering LDL-C.
H2 System Error. Please try after sometime.
H2 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H3 BECAUSE YOU’RE HUMAN
H3 APPROVED USE
H3 SUMMARY OF TERMS AND CONDITIONS
H3 I. ELIGIBILITY
H3 II.PROGRAM BENEFITS
H3 III.PROGRAM DETAILS
H4 Why Repatha®?
H6 Approved Use
NAV_HEADER_HEADING_REPEATED_FOOTER Amgen® SupportPlus Enrollment | Repatha® (evolocumab) (https://repatha.com/enrollment/)
Title

Amgen® SupportPlus Enrollment | Repatha® (evolocumab)

Meta

Enroll in Amgen® SupportPlus to access financial support and helpful resources to help you through your Repatha® (evolocumab) treatment. See Full Prescribing & Safety Info

H1 Get Helpful Resources With Amgen® SupportPlus
H2 Use your Repatha® (evolocumab) Co-Pay Card Today To Pay as Little as $25 for a 1-month supply or $50 for a 3-month supply.*
H2 Get Helpful Resources With Amgen® SupportPlus
H2 U.S. State Law Privacy Consents and Notice
H2 Additional Disclosures
H2 Get Helpful Resources With Amgen® SupportPlus
H2 Get Helpful Resources With Amgen® SupportPlus
H2 Patient Authorization and Consents
H2 Additional Disclosures
H2 System Error. Please try after sometime.
H2 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H3 The support you asked for + more to explore
H3 Program Enrollment – Patient Information
H3 What insurance do you use to pay for your Repatha® prescription?
H3 Are you eligible for Medicare but receiving prescription drug coverage from a former employer, union, or welfare plan?
H3 Based on the information you provided, please call Amgen® SupportPlus at 1-844-REPATHA (1-844-737-2842) to learn more about the ways Amgen SupportPlus can help you access your prescribed medication.
H3 Call Amgen® SupportPlus at 1-844-REPATHA (1-844-737-2842) Monday – Friday 8:00 am – 8:00 pm ET to learn more about the ways Amgen® SupportPlus can help you access your prescribed medication.
H3 Amgen® SupportPlus can provide your patients with information about independent nonprofit foundations that may be able to help.*
H3 Call Amgen® SupportPlus at 1-844-REPATHA to learn more.
H3 Based on your insurance selection patients like you may pay
H3 Welcome to personalized support designed just for you.
H3 Which additional Amgen® SupportPlus resources would you like to enroll in?
H3 Program Enrollment – Patient Information
H3 Answer the questions below to sign up for Repatha® reminders.
H3 Courtesy injection reminder
H3 How often do you take Repatha®?
H3 When would you like your first dose reminder?
H3 Courtesy refill reminder
H3 When would you like your first refill reminder?
H3 How often would you like to receive prescription refill reminders?
H3 Select communication preference
H3 Time Zone
H3 Complete the fields below to customize the Amgen® SupportPlus information, resources, and education you receive.
H3 What date were you prescribed Repatha®?
H3 When is your planned first dose of Repatha®?
H3 Select the Repatha® device that is prescribed for you.
H3 Congratulations—You Are Now Enrolled in Amgen® SupportPlus!
H3 Congratulations—You Are Now Re-Enrolled in Amgen® SupportPlus!
H3 You will also be receiving:
H3 Congratulations—You Are Now Enrolled in Amgen® SupportPlus!
H3 Congratulations—You Are Now Re-Enrolled in Amgen® SupportPlus!
H3 You will be receiving:
H3 Congratulations—You Are Now Enrolled in Amgen® SupportPlus!
H3 Congratulations—You Are Now Re-Enrolled in Amgen® SupportPlus!
H3 USE YOUR REPATHA® CO-PAY CARD TODAY TO PAY AS LITTLE AS $25 PER MONTH*
H3 You Are Now Enrolled in Amgen® SupportPlus!
H3 APPROVED USE
H3 SUMMARY OF TERMS AND CONDITIONS
H3 I. ELIGIBILITY
H3 II.PROGRAM BENEFITS
H3 III.PROGRAM DETAILS
H4 Healthcare Representative (Complete, if applicable)
H4 Based on your responses, you are eligible for the Repatha Co-Pay Card. To complete your enrollment, please read the full terms and conditions below and check the box to indicate your agreement.
H4 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H4 Over the coming weeks, you’ll receive personalized emails to help you navigate your Repatha® journey.
H4 Here are the additional services you have requested.
H4 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H5 Step 1 Of 2
H5 Step 2 Of 2
H5 SUMMARY OF TERMS AND CONDITIONS
H5 Treatment and/or Refill Reminders
H5 Amgen® Nurse Partners*
H5 Patient Brochure
H5 Sharps Disposal Container
H5 Step 1 Of 2
H5 Step 2 Of 2
H5 SUMMARY OF TERMS AND CONDITIONS
H6 Approved Use
H6 *Please make a selection
H6 *Please make a selection
H6 SureClick® Autoinjector
H6 Prefilled Syringe
H6 *Please make a selection
H6 *Please make a selection
HEADING_REPEATED_BODY Repatha® (evolocumab) Co-Pay Card Terms & Conditions (https://repatha.com/copaytcs/)
Title

Repatha® (evolocumab) Co-Pay Card Terms & Conditions

Meta

Find full terms and conditions for the Repatha® Co-Pay Card. See Full Prescribing & Safety info.

H1 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H2 Use your Repatha® (evolocumab) Co-Pay Card Today To Pay as Little as $25 for a 1-month supply or $50 for a 3-month supply.*
H2 SUMMARY OF TERMS AND CONDITIONS
H2 I. Eligibility
H2 II.  PROGRAM BENEFITS
H2 III. PROGRAM DETAILS
H2 System Error. Please try after sometime.
H2 REPATHA® (evolocumab) CO-PAY CARD TERMS & CONDITIONS
H3 The support you asked for + more to explore
H3 APPROVED USE
H3 SUMMARY OF TERMS AND CONDITIONS
H3 I. ELIGIBILITY
H3 II.PROGRAM BENEFITS
H3 III.PROGRAM DETAILS
H6 Approved Use
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://repatha.com) High Bad Cholesterol (LDL-C) Treatment | Repatha® (evolocumab)
Close

[H3]

[H1] Important Safety Information
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
What are the possible side effects of Repatha®?
Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
[H3] APPROVED USE
What is Repatha®?
Repatha® is an injectable prescription medicine used:
to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events.
Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).
Please see full Prescribing Information, including Patient Product Information.

Open

[H5]

IMPORTANT SAFETY INFORMATION
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex,
if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
3309 chars
SUB-PAGE (https://repatha.com/what-is-repatha/) What is Repatha® (evolocumab)?
What Is Repatha®?Repatha® is a breakthrough medicine that can help you dramaticallylower bad (LDL) cholesterol and
reduce your risk of heart attack.
[H4] Why Repatha®?

[H3] BECAUSE YOU’RE HUMAN

[IMG: Robot]

This is Sam. He does not have high bad cholesterol. He also performs tasks perfectly.
When trying to lower your cholesterol, you’re expected to be perfect—like Sam. And if you don’t swap a steak for a salad or you feel like watching your favorite TV show instead of exercising, you may feel judgment from the people who matter most to you.
But unlike Sam, you’re human. And although you do your best to exercise and maintain a healthy diet, you also want to experience the joy of what makes you human.

With help from Repatha®, you can lower your bad cholesterol while you enjoy life. Because You’re Human.

Every heart has its own story. Whether you’ve already had a heart attack or stroke or are working to reduce the risk of having one, Repatha® can help protect your heart from a major cardiovascular event, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery.

Help lower your LDL-C and your risk of
another heart attack or stroke with Repatha®

Help lower your LDL-C and risk of a
first heart attack with Repatha®

In a study of adults with cardiovascular disease taking statins, Repatha® was shown to help by:

Repatha® starts working quickly. In just 2 weeks, it starts working to bring LDL-C down, with a
[H2] 63%

average reduction in just 3 months.

[H2] 84%

of patients lowered high LDL-C to below 55 mg/dL in 1 month.
Everyone's recommended LDL-C level may be different. Talk to your doctor about what is right for you.

Proven to cut risk of a heart attack by
[H2] 27%

Patients not treated with Repatha® had more heart attacks (4.6%) compared to those treated with Repatha® (3.4%).

Proven to cut risk of a stroke by
[H2] 21%

Patients not treated with Repatha® had more strokes (1.9%) compared to those treated with Repatha® (1.5%).

Talk to your doctor about reducing your risk of a major cardiovascular event.

DOWNLOAD DOCTOR DISCUSSION GUIDE

In a study of adults at increased cardiovascular risk, who did not have a history of heart attack or stroke, and who may have already been on an additional LDL-C lowering treatment,* Repatha® was shown to help by:
*Any dose of statin with or without ezetimibe.

Repatha® lowered LDL-C by
[H2] 55%

[IMG: Diagram showing LDL-C level reduction after treatment]

Results from a subset of the study measured how much LDL-C was lowered over 48 weeks.

Repatha® cut risk of a first heart attack by

[H2] 36%

Patients not treated with Repatha® had more heart attacks (4.1%) compared to those treated with Repatha® (2.7%).

Talk to your doctor about reducing your risk of a major cardiovascular event.

DOWNLOAD DOCTOR DISCUSSION GUIDE

[H2] 10 Years of Impact.
Over 5 Million Patients Served Worldwide.*
Still Committed to Lowering LDL-C.

*Cumulative post-market exposure estimates from July 2015 through July 2025, on patients that have received at least 1 dose (estimates assume administration) of the product, which was estimated using prescription claims data (IQVIA) for the U.S. and units distributed (Amgen Finance Electronic Data Warehouse) with average drug utilization patterns (MarketScan claims data) for all other regions. Utilization assumptions were applied to calculate the unique number of patients.

[IMG: Headshot of Repatha® (evolocumab) Patient, Cathy]

“

With Repatha®, my LDL-C had dropped from over 100, down to 40.”
– CATHY, a real Repatha® patient who had a heart attack

HEAR MORE SUCCESS STORIES

Individual results may vary.

Repatha® Works Differently From a Statin
Take a look at this video that explains bad cholesterol and how to get yours down with Repatha®.

You've listened to your heart—now give it a voice.
[IMG: discussion-guide-v2]
It's important to talk to your doctor about your LDL-C. Not sure what to say? Our Doctor Discussion Guide can help you set goals and feel more supported as you head into that conversation.
You can download this guide, and consider bringing it to your next appointment.
[IMG: Illustration of cartoon heart pointing to the left]
DOWNLOAD GUIDE

I'VE HAD A HEART ATTACK

Jerry and his heart don't always agree.
So when it came to Repatha®, they talked it out.
Here's what happened.

Repatha® is also for people with an inherited condition that causes high bad cholesterol (called familial hypercholesterolemia, or FH), who still need to lower their bad cholesterol even though they diet and exercise.

For some people, poor diet, overweight/obesity, or low level of physical activity might not be the primary cause of high LDL-C. Sometimes high LDL-C is caused by an inherited condition called FH.

Heterozygous FH (HeFH) represents one form of this common genetic disorder that affects the liver’s ability to remove excess LDL-C. HeFH is an inherited condition, which means it is
caused by an abnormal gene that can be passed down from one of the parents. This can lead to premature cardiovascular disease, as well as other complications caused by high LDL-C.

Repatha® + a statin lowered LDL-C around an average of 60%.†
Repatha® drives LDL-C down in people with HeFH.

†Results from a study at week 12 compared to a placebo. Some patients were also on other cholesterol-lowering therapies. Repatha® was taken every 2 weeks or once monthly. Your results may vary.

Close

[H3]

[H1] Important Safety Information
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
What are the possible side effects of Repatha®?
Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
[H3] APPROVED USE
What is Repatha®?
Repatha® is an injectable prescription medicine used:
to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events.
Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).
Please see full Prescribing Information, including Patient Product Information.

Open

[H5]

IMPORTANT SAFETY INFORMATION
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex,
if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
9958 chars
SUB-PAGE (https://repatha.com/enrollment/) Amgen® SupportPlus Enrollment | Repatha® (evolocumab)
Close

[H3]

[H1] Important Safety Information
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
What are the possible side effects of Repatha®?
Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
[H3] APPROVED USE
What is Repatha®?
Repatha® is an injectable prescription medicine used:
to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events.
Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).
Please see full Prescribing Information, including Patient Product Information.

Open

[H5]

IMPORTANT SAFETY INFORMATION
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex,
if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
3309 chars
SUB-PAGE (https://repatha.com/copaytcs/) Repatha® (evolocumab) Co-Pay Card Terms & Conditions
Close

[H3]

[H1] Important Safety Information
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
What are the possible side effects of Repatha®?
Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
[H3] APPROVED USE
What is Repatha®?
Repatha® is an injectable prescription medicine used:
to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events.
Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).
Please see full Prescribing Information, including Patient Product Information.

Open

[H5]

IMPORTANT SAFETY INFORMATION
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex,
if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
3309 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
11Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 2 0
/what-is-repatha/ 2 0
/enrollment/ 4 0
/copaytcs/ 3 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/what-is-repatha/ — no schema detected (entity gap)
/enrollment/ — no schema detected (entity gap)
/copaytcs/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Repatha (Amgen) (repatha.com)

https://repatha.com 📍 Industry: Medical Devices, Pharma & Biotech
39 BS / 100

Repatha offers a substantive medical product packaged in an overly engineered ‘human-centric’ marketing shell. While the clinical data is robust and likely scientifically accurate, the site’s reliance on unverified patient stories and a total lack of structured data schema creates a measurable distance between its regulatory signal and its digital substance.

Info Density Power-words vs. Substance ratio.
9
30% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
3
15% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
8
40% BS
Commodity Fingerprint Detection of industry clichés/templates.
11
73% BS
Identity & Authority Expert verifiability & Schema depth.
8
53% BS

Replace the vague [H1] ‘Repatha® can help’ with a substance-led heading like ‘Repatha®: 63% Average LDL-C Reduction in 3 Months.’ Implement comprehensive Product and MedicalWebPage schema to bridge the technical authority gap. Add direct outbound citations to the peer-reviewed publications for the FOURIER or cardiovascular outcomes trials mentioned. Replace the robotic Sam metaphor with a technical ‘Mechanism of Action’ section to increase expert-level information density.

The site perfectly matches the Pharma & Biotech industry, evidenced by extensive ‘Important Safety Information’ blocks, ‘Approved Use’ declarations, and specific clinical data metrics for evolocumab. It follows high-compliance regulatory patterns typical of FDA-regulated prescription medication pages.

“The score of 39 is driven primarily by the Commodity Fingerprint (11) and Trust Theatre (8) pillars. While the site is medically substantive, its marketing delivery is highly derivative of standard pharma templates and it fails to provide verifiable links for its patient reviews or implement modern technical authority signals (Schema).”

Verified Analysis Date: June 19, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Brand AI Reputation